Journal club shortlist

Urology: this week's candidates

Clinical trials, guidelines and reviews that entered PubMed in the past 7 days, published in journals ranked Top 10% or higher within their own field. Updated every morning. Free, no account.

Clinical trials

5 this week

Major Adverse Cardiovascular Events in Men with High-risk Localized or Metastatic Prostate Cancer Starting Long-term Hormone Therapy in the STAMPEDE Trial

European urology · Top 5%

Efficacy and Safety of Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Non-BRCA Mutation Subgroup of Patients with Metastatic Castration-resistant Prostate Cancer in the PROpel Trial

European urology oncology · Top 5%

Phase I/II Study of Bavdegalutamide, a Proteolysis-Targeting Chimera Androgen Receptor Degrader, in Metastatic Castration-Resistant Prostate Cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · Top 5%

Tislelizumab plus lenvatinib in advanced fumarate hydratase-deficient renal cell carcinoma: a single-arm, phase 2 trial with metabolic biomarker analysis

Nature communications · Top 5%

Immunogenicity and safety of high-dose versus double-dose quadrivalent inactivated influenza vaccine in adult kidney transplant recipients: a randomized controlled trial (2023)

The Lancet regional health. Southeast Asia · Top 10%

Guidelines

0 this week

None this week at this bar.

Reviews and meta-analyses

14 this week

Mental health and urinary incontinence in childhood

The Lancet. Child & adolescent health · Top 5%

Cribriform and intraductal carcinoma in prostate cancer - implications for risk stratification and therapeutic decision-making

Nature reviews. Urology · Top 5%

Refining biopsy strategies stratified by PI-RADS score in men: a systematic review and network meta-analysis

Nature communications · Top 5%

Real-World Effectiveness of AI-Enabled Clinical Decision Support in Primary Care: Systematic Review

Journal of medical Internet research · Top 5%

Preclinical animal models of lower urinary tract dysfunction associated with metabolic syndrome

Nature reviews. Urology · Top 5%

Critical appraisal of artificial intelligence studies for prostate cancer detection on MRI

European radiology · Top 10%

FGFR-Altered Urothelial Carcinoma in the EV-Pembrolizumab Era: Rationale and Emerging Data for Upfront Triplet Strategies

Critical reviews in oncology/hematology · Top 10%

A bibliometric and visual analysis of research on echinocandin treatment for urinary tract infections based on VOSviewer and CiteSpace

Frontiers in cellular and infection microbiology · Top 10%

+ 6 more — the daily digest lists them all, by topic.

10 other articles from these journals are not listed yet: PubMed has not classified their article type, and we have not been able to determine it either. We do not guess.

Every morning, on your own topics.

€4.50 / month or €45 / year · free trial — 14 days without a card, 30 days with · cancel any time

Start free — 14 days, no card what the urology digest covers

Titles, journals and ranks only — Scienda never republishes abstracts. A journal's rank says nothing about any single article: read the paper. How urology journals are ranked · our method · set your own bar.

Other specialties